All Clinical Trials

< Back to search

Filter

Filter results

Results: 22,332

Nivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young AdultsNivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

Recruiting

PHASE2

Sponsor:

Sabine Mueller, MD, PhD

Location:

Birmingham AL, San Diego CA, San Francisco CA, Chicago ILshow 11 more

Code:

NCT05465174

Conditions

Craniopharyngioma, Child

Craniopharyngioma

Recurrent Craniopharyngioma

Eligibility Criteria

Sex: All

Age: 1 - 39

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Tovorafenib

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host DiseaseA Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Vancouver, Orlando FL, Pembroke Pines FL, Boston MAshow 3 more

Code:

NCT06585774

Conditions

Chronic Graft-versus-host-disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

INCA034176

Placebo

Corticosteroids

Natural History Study of Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL)Natural History Study of Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL)

Recruiting

Sponsor:

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Location:

Baltimore MD

Code:

NCT03624374

Conditions

Leukoencephalopathies

LBSL

Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation

White Matter Disease

Ataxia, Cerebellar

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Study of Olutasidenib and Temozolomide in HGGStudy of Olutasidenib and Temozolomide in HGG

Recruiting

PHASE2

Sponsor:

Rigel Pharmaceuticals

Location:

Aurora CO, Washington DC, Chicago IL, Boston MAshow 8 more

Code:

NCT06161974

Conditions

High Grade Glioma

Astrocytoma

Astrocytoma, Grade III

Astrocytoma, Grade IV

Diffuse Intrinsic Pontine Glioma

Eligibility Criteria

Sex: All

Age: 12 - 39

Healthy Volunteers: Not accepted

Interventions

Olutasidenib + TMZ

Improving Social Communication in Individuals With ASD Using AIImproving Social Communication in Individuals With ASD Using AI

Recruiting

Sponsor:

Stanford University

Location:

Stanford CA

Code:

NCT05987774

Conditions

Autism Spectrum Disorder

Eligibility Criteria

Sex: All

Age: 11 - 35

Healthy Volunteers: Not accepted

Interventions

AI Modules for Improving Social Conversation

Pilot Trial of Adaptive Radiotherapy Boost for HNSCCPilot Trial of Adaptive Radiotherapy Boost for HNSCC

Recruiting

Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Location:

Tampa FL

Code:

NCT06137274

Conditions

Squamous Cell Carcinoma

Head and Neck Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Intensity-modulated radiotherapy

Magnetic Resonance Guidance

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell LymphomaA Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Recruiting

PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Los Angeles CA, Orange CA, Sacramento CA, Indianapolis INshow 13 more

Code:

NCT06091865

Conditions

Diffuse Large B-cell Lymphoma (DLBCL)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Odronextamab

Rituximab

Cyclophosphamide

Doxorubicin

Vincristine

STUDY of the SAFETY and EFFICACY of MOXIDECTIN TABLETS for the REDUCTION of DEMODEX EYELASH INFESTATIONSTUDY of the SAFETY and EFFICACY of MOXIDECTIN TABLETS for the REDUCTION of DEMODEX EYELASH INFESTATION

Recruiting

Sponsor:

Eye Research Foundation, Inc.

Location:

Newport Beach CA

Code:

NCT06795165

Conditions

Blepharitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Moxidectin 2 MG Oral Tablet

Placebo

Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAHTrial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH

Recruiting

PHASE3

Sponsor:

University of Arizona

Location:

Tucson AZ

Code:

NCT04062565

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Treprostinil Injectable Product

Riociguat Pill

Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate CancerMagnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer

Recruiting

EARLY_PHASE1

Sponsor:

Robert Flavell, MD, PhD

Location:

San Francisco CA

Code:

NCT05851365

Conditions

Prostate Cancer

Localized Prostate Carcinoma

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Hyperpolarized Bicarbonate (13C)

Magnetic Resonance imaging

Filter

Filter results

Results: 22,332

Nivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young AdultsNivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

Recruiting

PHASE2

Sponsor:

Sabine Mueller, MD, PhD

Location:

Birmingham AL, San Diego CA, San Francisco CA, Chicago ILshow 11 more

Code:

NCT05465174

Conditions

Craniopharyngioma, Child

Craniopharyngioma

Recurrent Craniopharyngioma

Eligibility Criteria

Sex: All

Age: 1 - 39

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Tovorafenib

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host DiseaseA Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Vancouver, Orlando FL, Pembroke Pines FL, Boston MAshow 3 more

Code:

NCT06585774

Conditions

Chronic Graft-versus-host-disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

INCA034176

Placebo

Corticosteroids

Natural History Study of Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL)Natural History Study of Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL)

Recruiting

Sponsor:

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Location:

Baltimore MD

Code:

NCT03624374

Conditions

Leukoencephalopathies

LBSL

Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation

White Matter Disease

Ataxia, Cerebellar

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Study of Olutasidenib and Temozolomide in HGGStudy of Olutasidenib and Temozolomide in HGG

Recruiting

PHASE2

Sponsor:

Rigel Pharmaceuticals

Location:

Aurora CO, Washington DC, Chicago IL, Boston MAshow 8 more

Code:

NCT06161974

Conditions

High Grade Glioma

Astrocytoma

Astrocytoma, Grade III

Astrocytoma, Grade IV

Diffuse Intrinsic Pontine Glioma

Eligibility Criteria

Sex: All

Age: 12 - 39

Healthy Volunteers: Not accepted

Interventions

Olutasidenib + TMZ

Improving Social Communication in Individuals With ASD Using AIImproving Social Communication in Individuals With ASD Using AI

Recruiting

Sponsor:

Stanford University

Location:

Stanford CA

Code:

NCT05987774

Conditions

Autism Spectrum Disorder

Eligibility Criteria

Sex: All

Age: 11 - 35

Healthy Volunteers: Not accepted

Interventions

AI Modules for Improving Social Conversation

Pilot Trial of Adaptive Radiotherapy Boost for HNSCCPilot Trial of Adaptive Radiotherapy Boost for HNSCC

Recruiting

Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Location:

Tampa FL

Code:

NCT06137274

Conditions

Squamous Cell Carcinoma

Head and Neck Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Intensity-modulated radiotherapy

Magnetic Resonance Guidance

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell LymphomaA Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Recruiting

PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Los Angeles CA, Orange CA, Sacramento CA, Indianapolis INshow 13 more

Code:

NCT06091865

Conditions

Diffuse Large B-cell Lymphoma (DLBCL)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Odronextamab

Rituximab

Cyclophosphamide

Doxorubicin

Vincristine

STUDY of the SAFETY and EFFICACY of MOXIDECTIN TABLETS for the REDUCTION of DEMODEX EYELASH INFESTATIONSTUDY of the SAFETY and EFFICACY of MOXIDECTIN TABLETS for the REDUCTION of DEMODEX EYELASH INFESTATION

Recruiting

Sponsor:

Eye Research Foundation, Inc.

Location:

Newport Beach CA

Code:

NCT06795165

Conditions

Blepharitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Moxidectin 2 MG Oral Tablet

Placebo

Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAHTrial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH

Recruiting

PHASE3

Sponsor:

University of Arizona

Location:

Tucson AZ

Code:

NCT04062565

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Treprostinil Injectable Product

Riociguat Pill

Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate CancerMagnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer

Recruiting

EARLY_PHASE1

Sponsor:

Robert Flavell, MD, PhD

Location:

San Francisco CA

Code:

NCT05851365

Conditions

Prostate Cancer

Localized Prostate Carcinoma

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Hyperpolarized Bicarbonate (13C)

Magnetic Resonance imaging